QTc-interval prolongation associated with slow intravenous erythromycin lactobionate infusions in critically ill patients: a prospective evaluation and review of the literature.

Tschida, S J; Guay, D R; Straka, R J; Hoey, L L; Johanning, R; Vance-Bryan, K

Tschida, S J; Guay, D R; Straka, R J; Hoey, L L; Johanning, R; Vance-Bryan, K.

Affiliation

Tschida SJ; College of Pharmacy, University of Minnesota, Minneapolis, USA.

Pharmacotherapy ; 16(4): 663-74, 1996.

Article de En | MEDLINE | ID: mdl-8840374

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome du QT long / Érythromycine / Antibactériens Type d'étude: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Pharmacotherapy Année: 1996 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links